{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:19:02Z","timestamp":1788967142350,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"The Ministry of Science and Higher Education","award":["No N407691340"],"award-info":[{"award-number":["No N407691340"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.imlet.2017.03.005","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T20:21:29Z","timestamp":1488831689000},"page":"27-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Molecular and immunohistochemical expression of apoptotic proteins Bax, Bcl-2 and Caspase 3 in infantile hemangioma tissues as an effect of propranolol treatment"],"prefix":"10.1016","volume":"185","author":[{"given":"Aneta","family":"Wn\u0119k","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Andrzejewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f3zef","family":"Kobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Taran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw","family":"Przewratil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2017.03.005_bib0005","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/00006534-198203000-00002","article-title":"Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics","volume":"69","author":"Mulliken","year":"1982","journal-title":"Plastic Reconstr. Surg."},{"key":"10.1016\/j.imlet.2017.03.005_bib0010","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1001\/archderm.138.12.1567","article-title":"Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex","volume":"138","author":"Chiller","year":"2002","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.imlet.2017.03.005_bib0015","series-title":"Color Atlas of Vascular Tumors and Vascular Malformations","author":"Enjolras","year":"2007"},{"key":"10.1016\/j.imlet.2017.03.005_bib0020","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/j.1468-3083.2011.04102.x","article-title":"Infantile haemangioma: part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities","volume":"25","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.imlet.2017.03.005_bib0025","series-title":"Mulliken and Young\u2019s Vascular Anomalies: Hemangiomas and Malformations","year":"2013"},{"issue":"38","key":"10.1016\/j.imlet.2017.03.005_bib0030","first-page":"1","article-title":"Biology of infantile hemangioma","volume":"1","author":"Itinteang","year":"2014","journal-title":"Front. Surg."},{"issue":"12","key":"10.1016\/j.imlet.2017.03.005_bib0035","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.annder.2008.10.006","article-title":"Efficacy of beta-blockers in infantile capillary haemangiomas: the physiopathological significance and therapeutic consequences","volume":"135","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"Annal. Dermatol. Venereol."},{"key":"10.1016\/j.imlet.2017.03.005_bib0040","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cps.2004.10.001","article-title":"Current management of hemangiomas and vascular malformations","volume":"32","author":"Marler","year":"2005","journal-title":"Clin. Plast. Surg."},{"key":"10.1016\/j.imlet.2017.03.005_bib0045","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1097\/SCS.0b013e318193d6c1","article-title":"Infantile hemangioma: challenges, new insights, and therapeutic promise","volume":"1","author":"Boye","year":"2009","journal-title":"J. Craniofac. Surg."},{"key":"10.1016\/j.imlet.2017.03.005_bib0050","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1001\/archdermatol.2011.203","article-title":"Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis","volume":"147","author":"Price","year":"2011","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.imlet.2017.03.005_bib0055","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1542\/peds.2012-1691","article-title":"Initiation and use of propranolol for infantile hemangioma: report of a consensus conference","volume":"131","author":"Drolet","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.imlet.2017.03.005_bib0060","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00431-015-2570-0","article-title":"Treatment of infantile hemangioma: recommendations of a European expert group","volume":"164","author":"Hoeger","year":"2015","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.imlet.2017.03.005_bib0065","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1365-2133.2010.09848.x","article-title":"Propranolol for infantile hemangiomas: insight into the molecular mechanism of action","volume":"163","author":"Stroch","year":"2010","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"10.1016\/j.imlet.2017.03.005_bib0070","doi-asserted-by":"publisher","first-page":"52e","DOI":"10.1097\/SLA.0000000000000450","article-title":"Propranolol: a novel antihemangioma agent with multiple potential mechanisms of action","volume":"261","author":"Ji","year":"2015","journal-title":"Ann. Surg."},{"issue":"6","key":"10.1016\/j.imlet.2017.03.005_bib0075","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.3892\/or.2015.3911","article-title":"Propranolol represses infantile hemangioma cell growth through the \u03b22-adrenergic receptor in a HIF-1\u03b1-dependent manner","volume":"33","author":"Li","year":"2015","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.imlet.2017.03.005_bib0080","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal. Biochem."},{"issue":"3","key":"10.1016\/j.imlet.2017.03.005_bib0085","doi-asserted-by":"publisher","first-page":"e423","DOI":"10.1542\/peds.2008-3458","article-title":"Propranolol for severe infantile pcr metods hemangiomas: follow-up report","volume":"124","author":"Sans","year":"2009","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.imlet.2017.03.005_bib0090","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/lary.20807","article-title":"Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center","volume":"120","author":"Buckmiller","year":"2010","journal-title":"Laryngoscope"},{"key":"10.1016\/j.imlet.2017.03.005_bib0095","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00383-013-3283-y","article-title":"Propranolol therapy of infantile hemangiomas: efficacy, adverse effects, and recurrence","volume":"29","author":"Xiao","year":"2013","journal-title":"Pediatr. Surg. Int."},{"issue":"2","key":"10.1016\/j.imlet.2017.03.005_bib0100","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cyto.2009.11.012","article-title":"Local serum levels of vascular endothelial growth in infantie hemangioma: intriguing mechanism of endothelial growth","volume":"49","author":"Przewratil","year":"2010","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.imlet.2017.03.005_bib0105","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/SLA.0b013e318254ce7a","article-title":"Propranolol induces regression of hemangioma cells through HIF-1\u03b1-mediated inhibition of VEGF-A","volume":"256","author":"Chim","year":"2012","journal-title":"Ann. Surg."},{"issue":"30","key":"10.1016\/j.imlet.2017.03.005_bib0110","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/pde.12192","article-title":"Serum\u2013level changes of vascular endothelial growth factor in children with infantile hemangioma after oral propranolol therapy","volume":"5","author":"Chen","year":"2013","journal-title":"Pediatr. Dermatol."},{"issue":"1","key":"10.1016\/j.imlet.2017.03.005_bib0115","first-page":"48","article-title":"Propranolol inhibits angiogenesis via down-regulating the expression of vascular endothelial growth factor in hemangioma derived stem cell","volume":"7","author":"Zhang","year":"2014","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.imlet.2017.03.005_bib0120","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1016\/j.jpedsurg.2012.09.008","article-title":"Effects of propranolol on the proliferation and apoptosis of hemangioma-derived endothelial cells","volume":"47","author":"Ji","year":"2012","journal-title":"J. Pediatr. Surg."},{"key":"10.1016\/j.imlet.2017.03.005_bib0125","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3892\/etm.2013.1159","article-title":"Induction of apoptosis in infantile hemangioma endothelial cells by propranolol","volume":"6","author":"Tu","year":"2013","journal-title":"Exp. Ther. Med."},{"issue":"6","key":"10.1016\/j.imlet.2017.03.005_bib0130","first-page":"496","article-title":"Increased apoptosis and secretion of tryptase by mast cells in infantile haemangioma treated with propranolol","volume":"46","author":"Steel","year":"2014","journal-title":"Pathology (Phila.)"},{"key":"10.1016\/j.imlet.2017.03.005_bib0135","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1549-8719.1998.tb00068.x","article-title":"Increased apoptosis coincides with onset of involution in infantile hemangioma","volume":"5","author":"Razon","year":"1998","journal-title":"Microcirculation"},{"key":"10.1016\/j.imlet.2017.03.005_bib0140","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/00006534-200009010-00001","article-title":"Cellular and extracellular markers of hemangioma","volume":"106","author":"Tan","year":"2000","journal-title":"Plast. Reconstr. Surg."},{"issue":"4","key":"10.1016\/j.imlet.2017.03.005_bib0145","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s11596-006-0405-y","article-title":"Expression and significance of Bcl-2: Bax, Fas and caspase-3 in different phases of human hemangioma","volume":"26","author":"Yang","year":"2006","journal-title":"J. Huazhong Univ. Sci. Technol."},{"issue":"2","key":"10.1016\/j.imlet.2017.03.005_sbref0150a","first-page":"221","article-title":"Inhibitor of apoptosis proteins as intracellular signaling intermediates","volume":"282","author":"Kocab","year":"2016","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.imlet.2017.03.005_sbref0150b","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1549-8719.1998.tb00068.x","article-title":"Increased apoptosis coincides with onset of involution in infantile hemangioma","volume":"5","author":"Razon","year":"1998","journal-title":"Microcirculation"},{"issue":"11","key":"10.1016\/j.imlet.2017.03.005_bib0155","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/nrm1496","article-title":"Molecular mechanisms of caspase regulation during apoptosis","volume":"5","author":"Riedl","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.imlet.2017.03.005_bib0160","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/pr.2013.231","article-title":"Propranolol inhibits growth of hemangioma-initiating cells but does not induce apoptosis","volume":"75","author":"Kum","year":"2014","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.imlet.2017.03.005_bib0165","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1200\/JCO.2010.33.5422","article-title":"Beta blockers and breast cancer mortality: a population-based study","volume":"29","author":"Barron","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.imlet.2017.03.005_bib0170","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1158\/1055-9965.EPI-11-0249","article-title":"b-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study","volume":"20","author":"Lemeshow","year":"2011","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.imlet.2017.03.005_bib0175","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/jid.2014.373","article-title":"Inhibition of human melanoma growth by a non-cardioselective b-blocker","volume":"135","author":"Ludovic","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.imlet.2017.03.005_bib0180","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.imlet.2016.05.002","article-title":"Serum and tissue profile of VEGF and its receptors VGFR1\/R2 in children with infantile hemangiomas on systemic propranolol treatment","volume":"175","author":"Przewratil","year":"2016","journal-title":"Immunol. Lett."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247816302486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247816302486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T06:44:46Z","timestamp":1568875486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247816302486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":37,"alternative-id":["S0165247816302486"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2017.03.005","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular and immunohistochemical expression of apoptotic proteins Bax, Bcl-2 and Caspase 3 in infantile hemangioma tissues as an effect of propranolol treatment","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2017.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}